PUBLISHER: The Business Research Company | PRODUCT CODE: 1948338
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948338
Thoracic surgery devices encompass a diverse array of specialized instruments and equipment crafted for utilization in surgeries concerning the thorax, the region that encompasses vital structures such as the lungs, heart, and esophagus within the chest area. These devices are meticulously designed to afford surgeons precise control and enhanced visualization during surgical interventions, thereby minimizing the risk of complications and elevating overall patient outcomes.
The primary product categories within thoracic surgery devices include forceps, graspers, clamps and staplers, scissors, spreaders, needle holders, and various other instruments. Forceps, characterized as handheld and hinged tools, find application in medical and surgical procedures, serving functions such as grasping, holding, and applying traction, particularly in delicate surgical contexts. Diverse surgery types, including lobectomy, wedge resection, pneumonectomy, and others, make use of these devices, with end-users spanning hospitals, ambulatory surgical centers, and other medical settings.
Tariffs are affecting the thoracic surgery devices market by increasing costs for metal alloys, precision-engineered components, and finished surgical instruments such as forceps, graspers, clamps, staplers, spreaders, and needle holders that are commonly sourced through global supply chains, leading to higher procurement prices for hospitals and surgical centers. Regions with substantial import dependence across Europe, North America, and parts of Asia-Pacific are experiencing pricing pressure and longer sourcing cycles, particularly for premium and specialty thoracic instrument sets. However, tariffs have also encouraged localized production, regional sterilization and assembly operations, and supplier diversification, supporting domestic manufacturers and creating selective cost and availability advantages in certain markets.
The thoracic surgery devices market research report is one of a series of new reports from The Business Research Company that provides thoracic surgery devices market statistics, including thoracic surgery devices industry global market size, regional shares, competitors with a thoracic surgery devices market share, detailed thoracic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the thoracic surgery devices industry. This thoracic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thoracic surgery devices market size has grown strongly in recent years. It will grow from $9.67 billion in 2025 to $10.47 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing incidence of thoracic and pulmonary disorders requiring surgical intervention, rising usage of specialized clamps staplers and spreaders in open and minimally invasive procedures, expansion of hospital thoracic surgery programs and surgical infrastructure, growing clinical emphasis on operative precision and complication reduction, availability of diverse thoracic instrument configurations and sizes.
The thoracic surgery devices market size is expected to see strong growth in the next few years. It will grow to $14.34 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising demand for advanced instrument sets tailored to complex chest surgeries, increasing adoption of ergonomic and surgeon-friendly device designs, expansion of ambulatory thoracic surgery capabilities in select procedures, growing procedural volumes driven by aging population and chronic respiratory conditions, stronger focus on patient outcome improvement and post-operative recovery optimization. Major trends in the forecast period include increasing utilization of specialized thoracic forceps graspers clamps staplers and spreaders to support complex chest and lung surgeries, growing adoption of precision surgical instruments to enhance visualization control and accuracy during thoracic procedures, rising procedural volumes in lobectomy wedge resection and pneumonectomy driving demand for multi-functional instrument sets, expansion of thoracic surgery capability across hospitals and ambulatory surgical centers to improve patient access and outcomes, increasing preference for ergonomically designed needle holders scissors and retraction devices to support surgeon efficiency.
The rising prevalence of thoracic diseases is expected to drive the growth of the thoracic surgery device market going forward. Thoracic diseases include a wide range of conditions affecting the organs and structures within the thoracic cavity, such as the heart, lungs, esophagus, trachea, diaphragm, and major blood vessels. Thoracic surgery devices assist surgeons in performing procedures within the chest cavity, ensuring precision, efficacy, and patient safety. For example, in June 2023, according to the Australian Institute of Health and Welfare, an Australia-based government agency, chronic obstructive pulmonary disease (COPD) accounted for 3.6% of the total disease burden and represented 50% of the total respiratory disease burden in 2023. Therefore, the increasing prevalence of thoracic diseases is fueling the growth of the thoracic surgery device market.
Companies in the thoracic surgery device market are focusing on developing advanced plate and screw fixation systems to enhance post-surgical outcomes. One such innovation is the rigid internal sternal fixation system, a surgical device designed to stabilize and support the sternum using plates and screws, ensuring proper alignment and promoting bone healing after sternotomy or other thoracic procedures. For instance, in August 2024, DePuy Synthes, a US-based medical device company, launched the MatrixSTERNUM fixation system. This plate and screw system stabilizes the chest wall following open-heart and thoracic surgeries. It offers superior locking strength-three times greater than the leading competitor-enabling better sternum fixation during recovery. Its multi-hole screw guides allow rapid and accurate plate placement, reducing procedure time, while the 1.5 mm low-profile plates are thin, contourable, and minimally visible under the skin, improving patient comfort and surgical outcomes.
In August 2024, Getinge AB, a Sweden-based medical technology company, acquired Paragonix Technologies for approximately US$477 million. This acquisition aims to enhance Getinge's organ preservation and transplant logistics capabilities by integrating Paragonix's advanced organ transport and storage systems, thereby improving reliability and outcomes for heart and lung transplants. Paragonix Technologies is a US-based company specializing in organ preservation and transport solutions for cardiac and thoracic transplantation.
Major companies operating in the thoracic surgery devices market are Medtronic plc, Danaher Corporation, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical, Getinge AB, Teleflex Inc., Richard Wolf GmbH, Scanlan International, OmniGuide Holdings Inc., KLS Martin Group, Sklar Surgical Instruments, Dextera Surgical Inc., Biolitec AG, Johnson & Johnson, Cardio medical GmbH, LivaNova plc, Sinapi Biomedical, Medacta International SA, Aesculap AG, Medline Industries Inc
North America was the largest region in the thoracic surgery devices market in 2025. The regions covered in the thoracic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the thoracic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The thoracic surgery devices market includes revenues earned by entities by providing products such as thoracoscope, thoracic drainage systems, thoracic retractors and tissue sampling devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Thoracic Surgery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses thoracic surgery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for thoracic surgery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thoracic surgery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.